Generate a tailored SOP for Dr. Magnus Abrahamson. Improve your application with a focused, well-structured draft.
Magnus Abrahamson is a senior lecturer at Lund University, affiliated with the Division of Clinical Chemistry. He serves as the research team manager for the Protease Inhibitor Research Group and is a principal investigator in strategic research areas. His research primarily focuses on the role of cystatin C as a marker for kidney function and as a biomarker in cancer treatment, particularly within the context of amyloidosis. Abrahamson's work includes projects that aim to improve diagnostic tools for kidney diseases and cancer, with a focus on developing new urine markers and elucidating the therapeutic potential of cystatin C in cancer. He investigates cellular mechanisms and explores potential treatments for amyloid diseases, emphasizing the structural studies of cystatin C variants. His research aligns with UN Sustainable Development Goals, contributing valuable insights to medical and health sciences, particularly in oncology and molecular biology.
Lund University • Lund, Sweden
Leading research and teaching initiatives in clinical laboratory medicine.
Includes Master of Science in Politics and Society of the Contemporary Middle East and European Affairs.